CH due to mutations in TP53 have been shown to occur much more frequently among children with SDS (48%–76%) compared with aged-matched controls (<1%) although the frequency of other common CH mutations (DNMT3A, TET2, ASXL1) was comparable. Here, TP53 is linked to cyclic hematopoiesis.